corticotropin-releasing hormone and CSF cortisol concentrations were positively and significantly correlated. The authors concluded that veterans with PTSD have a higher CNS exposure to cortisol than that of healthy comparison subjects.
In a study assessing the cortisol response to a cognitive stress challenge, patients with PTSD had 61% higher group mean cortisol levels in the time leading up to the cognitive challenge and 46% higher cortisol levels during the period of the cognitive challenge compared with controls (Bremmer et al., 2003) . Most recently, glucocorticoids have been shown to induce PTSD-like memory impairments in mice (Kaouane, 2012) .
Intranasal insulin (40 IU) treatment of 26 healthy adult men minutes before they were exposed to the Trier Social Stress Test in a placebo-controlled, double-blind, between-subject design significantly diminished both the saliva and plasma cortisol response to the test (Bohringer et al., 2008) . Because intranasal insulin attenuates the hormonal response to stress in adult men, it may also be helpful as a way to treat and even protect against PTSD. If so, it would be possible to use insulin nasal sprays targeted to the upper third of the nasal cavity to treat individuals exposed to a traumatic stressful event shortly after it occurred or even to treat individuals, such as military personnel or first responders, who are at immediate high risk for traumatic stress to help protect the brain against the damaging effects of such stress. DISCLOSURES Dr Frey's work is supported by private donors who give generous donations to support the development of new methods of treatment and prevention of AD and related disorders, by the pharmaceutical and biotechnology industry, by the National Institute of Aging, and by the Veterans Administration.
Dr Frey is the listed inventor on numerous patents related to intranasal therapeutics to treat brain disorders but does not have an issued patent or published patent application related to intranasal insulin treatment of PTSD. He consults for many pharmaceutical and biotechnology companies.
